Cargando…

LncSHRG promotes hepatocellular carcinoma progression by activating HES6

Hepatocellular carcinoma, one of the most common cancers, leads to mass mortality worldwide currently. However, the underlying mechanism of its oncogenesis remains to be elucidated. Here we identified that a long noncoding RNA, lncSHRG, was greatly upregulated in human hepatocellular carcinoma sampl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Ying-Chen, Liang, Chao-Jie, Zhang, Dong-Xin, Li, Guan-Qun, Gao, Xia, Fu, Jian-Zhu, Xia, Feng, Ji, Jia-Jun, Zhang, Li-Jun, Li, Guang-Ming, Wu, Ji-Xiang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Impact Journals LLC 2017
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5642582/ https://www.ncbi.nlm.nih.gov/pubmed/29050307 http://dx.doi.org/10.18632/oncotarget.19906

Ejemplares similares

Sumoylation of Hes6 Regulates Protein Degradation and Hes1-Mediated Transcription
por: Lee, Jiwon, et al.
Publicado: (2015)

HES6-1 and HES6-2 Function through Different Mechanisms during Neuronal Differentiation
por: Vilas-Boas, Filipe, et al.
Publicado: (2010)

The novel GATA1-interacting protein HES6 is an essential transcriptional cofactor for human erythropoiesis
por: Wang, Zi, et al.
Publicado: (2023)

Targeted delivery of HES5-siRNA with novel polypeptide-modified nanoparticles for hepatocellular carcinoma therapy
por: Xia, Yu, et al.
Publicado: (2018)

Hyperhomocysteinemia induces injury in olfactory bulb neurons by downregulating Hes1 and Hes5 expression
por: Zhang, Jing-wen, et al.
Publicado: (2018)

Hes-6, an inhibitor of Hes-1, is regulated by 17β-estradiol and promotes breast cancer cell proliferation
por: Hartman, Johan, et al.
Publicado: (2009)

He’s Come!!
por: Stewart, A. T.
Publicado: (1869)

Identification of Glycolysis-Related lncRNAs and the Novel lncRNA WAC-AS1 Promotes Glycolysis and Tumor Progression in Hepatocellular Carcinoma
por: Xia, Xigang, et al.
Publicado: (2021)

KDM6B Negatively Regulates the Neurogenesis Potential of Apical Papilla Stem Cells via HES1
por: Zhang, Chen, et al.
Publicado: (2023)

LncRNA CSMD1-1 promotes the progression of Hepatocellular Carcinoma by activating MYC signaling
por: Liu, Ji, et al.
Publicado: (2020)

Circadian regulation of low density lipoprotein receptor promoter activity by CLOCK/BMAL1, Hes1 and Hes6
por: Lee, Yeon-Ju, et al.
Publicado: (2012)

Recent advances in understanding the role of HES6 in cancers
por: Krossa, Imène, et al.
Publicado: (2022)

Hey2 functions in parallel with Hes1 and Hes5 for mammalian auditory sensory organ development
por: Li, Shuangding, et al.
Publicado: (2008)

Molecular pattern of lncRNAs in hepatocellular carcinoma
por: Mai, Haoming, et al.
Publicado: (2019)

LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma
por: Hu, Jiangfeng, et al.
Publicado: (2017)

Hes6 Is Required for the Neurogenic Activity of Neurogenin and NeuroD
por: Murai, Kasumi, et al.
Publicado: (2011)

PB2204: THE ROLE OF HES6 IN NORMAL HUMAN HEMATOPOIESIS
por: De Vos, T., et al.
Publicado: (2022)

Prospective observational study for perioperative volume replacement with 6% HES 130/0,42, 4% gelatin and 6% HES 200/0,5 in cardiac surgery
por: Winterhalter, M, et al.
Publicado: (2010)

Comparison of 6% HES 130/0.4 in a balanced electrolyte solution versus 6% HES 130/0.4 in saline solution in cardiac surgery
por: Base, E, et al.
Publicado: (2006)

TLE4 acts as a corepressor of Hes1 to inhibit inflammatory responses in macrophages
por: Zhang, Xiang, et al.
Publicado: (2018)

Changes in the degree of substitution of HES in vivo and their influence on methods for determining HES concentrations in plasma
por: Lukasewitz, Peter, et al.
Publicado: (2023)

Correction to: Molecular pattern of lncRNAs in hepatocellular carcinoma
por: Mai, Haoming, et al.
Publicado: (2019)

LncRNA-SNHG6 promotes the progression of hepatocellular carcinoma by targeting miR-6509-5p and HIF1A
por: Fan, Xiaoxi, et al.
Publicado: (2021)

LncRNA LIFR‐AS1 overexpression suppressed the progression of serous ovarian carcinoma
por: Liu, Fang, et al.
Publicado: (2022)

Correction: LncRNA-SVUGP2 suppresses progression of hepatocellular carcinoma
por: Hu, Jiangfeng, et al.
Publicado: (2018)

HES6 promotes prostate cancer aggressiveness independently of Notch signalling
por: Carvalho, Filipe L F, et al.
Publicado: (2015)

LncRNA HOXA11‐AS promotes hepatocellular carcinoma progression by repressing miR‐214‐3p
por: Zhan, Meixiao, et al.
Publicado: (2018)

‘When he’s up there he’s just happy and content’: Parents’ perceptions of therapeutic horseback riding
por: Boyd, Lauren, et al.
Publicado: (2017)

LncRNA MANCR positively affects the malignant progression of lung adenocarcinoma
por: Liu, Chang, et al.
Publicado: (2021)

MLL1 inhibits the neurogenic potential of SCAPs by interacting with WDR5 and repressing HES1
por: Zhang, Chen, et al.
Publicado: (2023)

Hypomethylation‐mediated activation of cancer/testis antigen KK‐LC‐1 facilitates hepatocellular carcinoma progression through activating the Notch1/Hes1 signalling
por: Chen, Zhiqiang, et al.
Publicado: (2019)

Evolution of hes gene family in vertebrates: the hes5 cluster genes have specifically increased in frogs
por: Kuretani, Aya, et al.
Publicado: (2021)

The clinicopathological significance of HES1 promoter hypomethylation in patients with colorectal cancer
por: Wu, Yinfang, et al.
Publicado: (2017)

Role of lncRNA NR2F1-AS1 and lncRNA H19 Genes in Hepatocellular Carcinoma and Their Effects on Biological Function of Huh-7
por: Ji, Wen-Chao, et al.
Publicado: (2021)

Downregulation of Hes1 expression in experimental biliary atresia and its effects on bile duct structure
por: Zhang, Rui-Zhong, et al.
Publicado: (2018)

XB130 Knockdown Inhibits the Proliferation, Invasiveness, and Metastasis of Hepatocellular Carcinoma Cells and Sensitizes them to TRAIL-Induced Apoptosis
por: Li, Guang-Ming, et al.
Publicado: (2018)

DOT1L-HES6 fusion drives androgen independent growth in prostate cancer
por: Annala, Matti, et al.
Publicado: (2014)

The expressions of bHLH gene HES1 and HES5 in advanced ovarian serous adenocarcinomas and their prognostic significance: a retrospective clinical study
por: Wang, Xinyu, et al.
Publicado: (2009)

HES 130/0.4, a new HES specification: tissue storage after multiple infusions in rats
por: Bepperling, F, et al.
Publicado: (1999)

CBX6 overexpression contributes to tumor progression and is predictive of a poor prognosis in hepatocellular carcinoma
por: Zheng, Hao, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_3oplfe66h9s0f3i5md420fe8ai